MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 232 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $440,040 | -92.6% | 1,570 | -93.0% | 0.00% | -100.0% |
| Q1 2024 | $5,949,587 | +51.7% | 22,357 | +31.9% | 0.00% | +33.3% |
| Q4 2023 | $3,921,660 | +88.5% | 16,949 | +19.0% | 0.00% | +50.0% |
| Q3 2023 | $2,080,048 | -36.8% | 14,243 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $3,290,133 | +24.7% | 14,243 | +30.8% | 0.00% | 0.0% |
| Q1 2023 | $2,638,211 | – | 10,890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |